Long-Term Tolvaptan Treatment in Refractory Heart Failure.

Circ Rep · 2019 · PMC7897549 · PMID 33693080

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Despite a moderate sample size, we still observed significant advantages of tolvaptan therapy in the primary endpoint, although several secondary outcomes did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.